Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A).
- DOI
- 10.1007/s00109-026-02677-7
- Published
- 2026 Apr 28
- Container
- Journal of molecular medicine (Berlin, Germany)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00109-026-02677-7,
title = {Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A).},
author = {Rice K and Lehtinen N and Välimäki E and Suhonen J and Taimen P and Kettunen K and Ventelä S and Kononen J and Sihto H and Rantala JK},
year = {2026},
journal = {Journal of molecular medicine (Berlin, Germany)},
doi = {10.1007/s00109-026-02677-7},
url = {https://doi.org/10.1007/s00109-026-02677-7}
}RIS
TY - JOUR TI - Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A). AU - Rice K AU - Lehtinen N AU - Välimäki E AU - Suhonen J AU - Taimen P AU - Kettunen K AU - Ventelä S AU - Kononen J AU - Sihto H AU - Rantala JK PY - 2026 JO - Journal of molecular medicine (Berlin, Germany) DO - 10.1007/s00109-026-02677-7 UR - https://doi.org/10.1007/s00109-026-02677-7 ER -
APA
K, R., N, L., E, V., J, S., P, T., K, K., S, V., J, K., H, S., & JK, R. (2026). Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A).. Journal of molecular medicine (Berlin, Germany). https://doi.org/10.1007/s00109-026-02677-7
Source records
- pubmed · retrieved 2026-09-25T07:26:36.563Z